Canaccord’s Lynne Collier sees meaningful upside waiting in the next one to two years for CMG’s comeback.

Though Susquehanna’s Christopher Rolland now spotlights 26% in loss potential for AMD stock- remaining bearish despite a better quarterly performance.

RBC Capital’s Ross MacMillan continues to be impressed with Azure demand as he previews MSFT’s fiscal earnings out tonight.

Wedbush’s Michael Pachter is confident this e-commerce leader is set to dish out meaningful earnings long-term- and Q1 sales upside after the bell.

RBC Capital’s Amit Daryanani now spotlights 3% in upside potential for INTC stock.

After the bell, Facebook (NASDAQ:FB) delivered its much anticipated first-quarter results which came in ahead …

Advanced Micro Devices (NASDAQ:AMD) is on a comeback based on first-quarter earnings results reported this …

Can you feel the ground moving beneath your feet? Shares of Facebook (NASDAQ:FB) soared nearly …

Tigress’ Ivan Feinseth spotlights any share weakness as an enticing opportunity to buy SQ stock.

Baird’s Colin Sebastian is reassured to see solid key metrics that led to Twitter’s outclass on Q1 expectations- but here’s why he remains sidelined;

Credit Suisse’s John Pitzer spotlights that while crypto GPU revenue is “waning” in steam, in the short-term up to $200 million in upside could be waiting in the wings.

Montana Skeptic is a well known Tesla (NASDAQ:TSLA) skeptic and short seller who writes frequently …

Nasdaq-halted Longfin (NASDAQ:LFIN) is now in an ‘Event of Default’ with respect to its $52.7M convertible …

It’s been a rough few weeks for social media giant Facebook (NASDAQ:FB). As we discussed just …

Last week, vTv Therapeutics Inc (NASDAQ:VTVT) announced that azeliragon, the company’s RAGE inhibitor in development …

What does the future hold for Tesla (NASDAQ:TSLA) and Twitter (NYSE:TWTR)? Sell-side analysts from Bernstein and Morgan …

Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small …